Diamond Biotechnology Co., Ltd (TPEX:6815)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Personal Products	501.49M	768.25M	616.10M	434.84M	395.20M
Personal Products Growth	-34.72%	24.70%	41.68%	10.03%	28.99%
Total	501.49M	768.25M	616.10M	434.84M	395.20M
Total Growth	-34.72%	24.70%	41.68%	10.03%	28.99%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Mainland China	67.27M	44.26M	21.00K	-	142.00K
Mainland China Growth	51.97%	210680.95%	-	-	-94.24%
Taiwan	434.23M	723.99M	616.08M	434.84M	395.06M
Taiwan Growth	-40.02%	17.52%	41.68%	10.07%	29.99%
Total	501.49M	768.25M	616.10M	434.84M	395.20M
Total Growth	-34.72%	24.70%	41.68%	10.03%	28.99%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 9, 2026

Data Sources Report a data error